1 GIP And Glucagon Receptor Agonist For Obesity Therapy

The overall pooled analysis showed a statistically substantial percent decrease in body weight of the retatrutide group when contrasted to the sugar pill group after 36 weeks of treatment, with an overall MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide cost per month</a> in obese patients with or without diabetes. Early trials of retatrutide disclosed that individuals can shed approximately a quarter of their body weight in under a year, making it almost two times as efficient as Ozempic.